End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.49 CNY | -0.94% | -5.38% | -12.37% |
15/05 | Tonghua Dongbao Pharmaceutical Launches Phase 1 Trial for Diabetes Injection in China | MT |
10/05 | Dongbao Pharmaceutical's Deputy General Manager to Reduce Stake | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.37% | 260.83Cr | |
-2.00% | 9.03TCr | |
-1.18% | 4.01TCr | |
-15.80% | 3.17TCr | |
+62.86% | 2.66TCr | |
-21.72% | 1.44TCr | |
-8.63% | 1.29TCr | |
-15.05% | 1.14TCr | |
-45.69% | 1.13TCr | |
+4.94% | 886.85Cr |
- Stock Market
- Equities
- 600867 Stock
- News Tonghua Dongbao Pharmaceutical Co., Ltd.
- Tonghua Dongbao Pharmaceutical Enrolls First Subject for Phase II Trial of Gout Drug; Shares Rose 4%